nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—migraine—Prednisone—systemic scleroderma	0.908	1	CpDpCtD
Orphenadrine—Gastric irritation—Captopril—systemic scleroderma	0.00503	0.0545	CcSEcCtD
Orphenadrine—Epigastric discomfort—Captopril—systemic scleroderma	0.00371	0.0402	CcSEcCtD
Orphenadrine—Aplastic anaemia—Pentoxifylline—systemic scleroderma	0.00241	0.0262	CcSEcCtD
Orphenadrine—Gastric irritation—Prednisone—systemic scleroderma	0.00211	0.0229	CcSEcCtD
Orphenadrine—Aplastic anaemia—Azathioprine—systemic scleroderma	0.0016	0.0173	CcSEcCtD
Orphenadrine—Epigastric discomfort—Prednisone—systemic scleroderma	0.00156	0.0169	CcSEcCtD
Orphenadrine—Drowsiness—Pentoxifylline—systemic scleroderma	0.00144	0.0156	CcSEcCtD
Orphenadrine—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00114	0.0123	CcSEcCtD
Orphenadrine—Tension—Pentoxifylline—systemic scleroderma	0.0011	0.012	CcSEcCtD
Orphenadrine—Vision blurred—Pentoxifylline—systemic scleroderma	0.00106	0.0115	CcSEcCtD
Orphenadrine—Tremor—Pentoxifylline—systemic scleroderma	0.00105	0.0114	CcSEcCtD
Orphenadrine—Agitation—Pentoxifylline—systemic scleroderma	0.00103	0.0112	CcSEcCtD
Orphenadrine—Palpitations—Pentoxifylline—systemic scleroderma	0.000993	0.0108	CcSEcCtD
Orphenadrine—Hallucination—Captopril—systemic scleroderma	0.000974	0.0106	CcSEcCtD
Orphenadrine—Confusional state—Pentoxifylline—systemic scleroderma	0.000925	0.01	CcSEcCtD
Orphenadrine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.000917	0.00995	CcSEcCtD
Orphenadrine—Tachycardia—Pentoxifylline—systemic scleroderma	0.000895	0.00971	CcSEcCtD
Orphenadrine—Skin disorder—Pentoxifylline—systemic scleroderma	0.000891	0.00966	CcSEcCtD
Orphenadrine—Tension—Captopril—systemic scleroderma	0.000836	0.00906	CcSEcCtD
Orphenadrine—Somnolence—Pentoxifylline—systemic scleroderma	0.000816	0.00884	CcSEcCtD
Orphenadrine—Vision blurred—Captopril—systemic scleroderma	0.000803	0.00871	CcSEcCtD
Orphenadrine—Anaphylactic shock—Mometasone—systemic scleroderma	0.000792	0.00858	CcSEcCtD
Orphenadrine—Constipation—Pentoxifylline—systemic scleroderma	0.000784	0.00851	CcSEcCtD
Orphenadrine—Hallucination—Mycophenolic acid—systemic scleroderma	0.000766	0.0083	CcSEcCtD
Orphenadrine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000756	0.0082	CcSEcCtD
Orphenadrine—Palpitations—Captopril—systemic scleroderma	0.000753	0.00816	CcSEcCtD
Orphenadrine—Urticaria—Pentoxifylline—systemic scleroderma	0.000729	0.0079	CcSEcCtD
Orphenadrine—Confusional state—Captopril—systemic scleroderma	0.000701	0.0076	CcSEcCtD
Orphenadrine—Anaphylactic shock—Captopril—systemic scleroderma	0.000695	0.00754	CcSEcCtD
Orphenadrine—Hallucination—Lisinopril—systemic scleroderma	0.00069	0.00748	CcSEcCtD
Orphenadrine—Tachycardia—Captopril—systemic scleroderma	0.000679	0.00736	CcSEcCtD
Orphenadrine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000676	0.00733	CcSEcCtD
Orphenadrine—Vision blurred—Leflunomide—systemic scleroderma	0.000662	0.00718	CcSEcCtD
Orphenadrine—Asthenia—Pentoxifylline—systemic scleroderma	0.000658	0.00714	CcSEcCtD
Orphenadrine—Tension—Mycophenolic acid—systemic scleroderma	0.000657	0.00713	CcSEcCtD
Orphenadrine—Pruritus—Pentoxifylline—systemic scleroderma	0.000649	0.00704	CcSEcCtD
Orphenadrine—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000643	0.00697	CcSEcCtD
Orphenadrine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000631	0.00684	CcSEcCtD
Orphenadrine—Tremor—Mycophenolic acid—systemic scleroderma	0.000627	0.0068	CcSEcCtD
Orphenadrine—Palpitations—Leflunomide—systemic scleroderma	0.00062	0.00673	CcSEcCtD
Orphenadrine—Somnolence—Captopril—systemic scleroderma	0.000618	0.0067	CcSEcCtD
Orphenadrine—Agitation—Mycophenolic acid—systemic scleroderma	0.000615	0.00667	CcSEcCtD
Orphenadrine—Dizziness—Pentoxifylline—systemic scleroderma	0.000607	0.00658	CcSEcCtD
Orphenadrine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000604	0.00655	CcSEcCtD
Orphenadrine—Constipation—Captopril—systemic scleroderma	0.000595	0.00645	CcSEcCtD
Orphenadrine—Tension—Lisinopril—systemic scleroderma	0.000592	0.00642	CcSEcCtD
Orphenadrine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000592	0.00642	CcSEcCtD
Orphenadrine—Skin disorder—Azathioprine—systemic scleroderma	0.000589	0.00639	CcSEcCtD
Orphenadrine—Vomiting—Pentoxifylline—systemic scleroderma	0.000583	0.00632	CcSEcCtD
Orphenadrine—Headache—Pentoxifylline—systemic scleroderma	0.000575	0.00623	CcSEcCtD
Orphenadrine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000573	0.00621	CcSEcCtD
Orphenadrine—Feeling abnormal—Captopril—systemic scleroderma	0.000573	0.00621	CcSEcCtD
Orphenadrine—Vision blurred—Lisinopril—systemic scleroderma	0.000569	0.00617	CcSEcCtD
Orphenadrine—Asthenia—Mometasone—systemic scleroderma	0.000568	0.00616	CcSEcCtD
Orphenadrine—Tremor—Lisinopril—systemic scleroderma	0.000565	0.00613	CcSEcCtD
Orphenadrine—Pruritus—Mometasone—systemic scleroderma	0.00056	0.00607	CcSEcCtD
Orphenadrine—Tachycardia—Leflunomide—systemic scleroderma	0.000559	0.00606	CcSEcCtD
Orphenadrine—Skin disorder—Leflunomide—systemic scleroderma	0.000557	0.00604	CcSEcCtD
Orphenadrine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000551	0.00598	CcSEcCtD
Orphenadrine—Nausea—Pentoxifylline—systemic scleroderma	0.000545	0.00591	CcSEcCtD
Orphenadrine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000533	0.00579	CcSEcCtD
Orphenadrine—Palpitations—Lisinopril—systemic scleroderma	0.000533	0.00578	CcSEcCtD
Orphenadrine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000531	0.00576	CcSEcCtD
Orphenadrine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000519	0.00562	CcSEcCtD
Orphenadrine—Vomiting—Mometasone—systemic scleroderma	0.000503	0.00546	CcSEcCtD
Orphenadrine—Feeling abnormal—Azathioprine—systemic scleroderma	0.0005	0.00542	CcSEcCtD
Orphenadrine—Asthenia—Captopril—systemic scleroderma	0.000499	0.00541	CcSEcCtD
Orphenadrine—Confusional state—Lisinopril—systemic scleroderma	0.000496	0.00538	CcSEcCtD
Orphenadrine—Headache—Mometasone—systemic scleroderma	0.000496	0.00538	CcSEcCtD
Orphenadrine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000495	0.00537	CcSEcCtD
Orphenadrine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000492	0.00534	CcSEcCtD
Orphenadrine—Pruritus—Captopril—systemic scleroderma	0.000492	0.00533	CcSEcCtD
Orphenadrine—Constipation—Leflunomide—systemic scleroderma	0.00049	0.00531	CcSEcCtD
Orphenadrine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000486	0.00527	CcSEcCtD
Orphenadrine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000486	0.00527	CcSEcCtD
Orphenadrine—Tachycardia—Lisinopril—systemic scleroderma	0.000481	0.00521	CcSEcCtD
Orphenadrine—Skin disorder—Lisinopril—systemic scleroderma	0.000478	0.00519	CcSEcCtD
Orphenadrine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000472	0.00512	CcSEcCtD
Orphenadrine—Nausea—Mometasone—systemic scleroderma	0.00047	0.0051	CcSEcCtD
Orphenadrine—Constipation—Mycophenolic acid—systemic scleroderma	0.000467	0.00507	CcSEcCtD
Orphenadrine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000467	0.00507	CcSEcCtD
Orphenadrine—Dizziness—Captopril—systemic scleroderma	0.00046	0.00499	CcSEcCtD
Orphenadrine—Urticaria—Leflunomide—systemic scleroderma	0.000455	0.00494	CcSEcCtD
Orphenadrine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00045	0.00488	CcSEcCtD
Orphenadrine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000447	0.00485	CcSEcCtD
Orphenadrine—Vomiting—Captopril—systemic scleroderma	0.000442	0.00479	CcSEcCtD
Orphenadrine—Somnolence—Lisinopril—systemic scleroderma	0.000438	0.00475	CcSEcCtD
Orphenadrine—Headache—Captopril—systemic scleroderma	0.000436	0.00472	CcSEcCtD
Orphenadrine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000435	0.00472	CcSEcCtD
Orphenadrine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000431	0.00468	CcSEcCtD
Orphenadrine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000422	0.00458	CcSEcCtD
Orphenadrine—Constipation—Lisinopril—systemic scleroderma	0.000421	0.00457	CcSEcCtD
Orphenadrine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000421	0.00457	CcSEcCtD
Orphenadrine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000419	0.00454	CcSEcCtD
Orphenadrine—Nausea—Captopril—systemic scleroderma	0.000413	0.00448	CcSEcCtD
Orphenadrine—Asthenia—Leflunomide—systemic scleroderma	0.000411	0.00446	CcSEcCtD
Orphenadrine—Hallucination—Prednisone—systemic scleroderma	0.00041	0.00444	CcSEcCtD
Orphenadrine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000406	0.0044	CcSEcCtD
Orphenadrine—Pruritus—Leflunomide—systemic scleroderma	0.000405	0.0044	CcSEcCtD
Orphenadrine—Dizziness—Azathioprine—systemic scleroderma	0.000401	0.00435	CcSEcCtD
Orphenadrine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000392	0.00425	CcSEcCtD
Orphenadrine—Urticaria—Lisinopril—systemic scleroderma	0.000391	0.00424	CcSEcCtD
Orphenadrine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000387	0.00419	CcSEcCtD
Orphenadrine—Vomiting—Azathioprine—systemic scleroderma	0.000386	0.00418	CcSEcCtD
Orphenadrine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000383	0.00416	CcSEcCtD
Orphenadrine—Drowsiness—Methotrexate—systemic scleroderma	0.000383	0.00416	CcSEcCtD
Orphenadrine—Headache—Azathioprine—systemic scleroderma	0.00038	0.00412	CcSEcCtD
Orphenadrine—Dizziness—Leflunomide—systemic scleroderma	0.000379	0.00411	CcSEcCtD
Orphenadrine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000369	0.004	CcSEcCtD
Orphenadrine—Vomiting—Leflunomide—systemic scleroderma	0.000364	0.00395	CcSEcCtD
Orphenadrine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000363	0.00393	CcSEcCtD
Orphenadrine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000361	0.00392	CcSEcCtD
Orphenadrine—Nausea—Azathioprine—systemic scleroderma	0.00036	0.00391	CcSEcCtD
Orphenadrine—Headache—Leflunomide—systemic scleroderma	0.000359	0.00389	CcSEcCtD
Orphenadrine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000355	0.00385	CcSEcCtD
Orphenadrine—Asthenia—Lisinopril—systemic scleroderma	0.000353	0.00383	CcSEcCtD
Orphenadrine—Pruritus—Lisinopril—systemic scleroderma	0.000348	0.00378	CcSEcCtD
Orphenadrine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000348	0.00377	CcSEcCtD
Orphenadrine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000343	0.00372	CcSEcCtD
Orphenadrine—Headache—Mycophenolic acid—systemic scleroderma	0.000342	0.00371	CcSEcCtD
Orphenadrine—Nausea—Leflunomide—systemic scleroderma	0.00034	0.00369	CcSEcCtD
Orphenadrine—Vision blurred—Prednisone—systemic scleroderma	0.000338	0.00366	CcSEcCtD
Orphenadrine—Agitation—Prednisone—systemic scleroderma	0.000329	0.00357	CcSEcCtD
Orphenadrine—Dizziness—Lisinopril—systemic scleroderma	0.000326	0.00353	CcSEcCtD
Orphenadrine—Nausea—Mycophenolic acid—systemic scleroderma	0.000325	0.00352	CcSEcCtD
Orphenadrine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00345	CcSEcCtD
Orphenadrine—Vomiting—Lisinopril—systemic scleroderma	0.000313	0.00339	CcSEcCtD
Orphenadrine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000309	0.00336	CcSEcCtD
Orphenadrine—Headache—Lisinopril—systemic scleroderma	0.000308	0.00334	CcSEcCtD
Orphenadrine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000305	0.00331	CcSEcCtD
Orphenadrine—Nausea—Lisinopril—systemic scleroderma	0.000292	0.00317	CcSEcCtD
Orphenadrine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000292	0.00317	CcSEcCtD
Orphenadrine—Tachycardia—Prednisone—systemic scleroderma	0.000285	0.00309	CcSEcCtD
Orphenadrine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00309	CcSEcCtD
Orphenadrine—Skin disorder—Prednisone—systemic scleroderma	0.000284	0.00308	CcSEcCtD
Orphenadrine—Vision blurred—Methotrexate—systemic scleroderma	0.000282	0.00306	CcSEcCtD
Orphenadrine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000274	0.00297	CcSEcCtD
Orphenadrine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00027	0.00293	CcSEcCtD
Orphenadrine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00278	CcSEcCtD
Orphenadrine—Constipation—Prednisone—systemic scleroderma	0.00025	0.00271	CcSEcCtD
Orphenadrine—Confusional state—Methotrexate—systemic scleroderma	0.000246	0.00267	CcSEcCtD
Orphenadrine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000244	0.00265	CcSEcCtD
Orphenadrine—Feeling abnormal—Prednisone—systemic scleroderma	0.000241	0.00261	CcSEcCtD
Orphenadrine—Skin disorder—Methotrexate—systemic scleroderma	0.000237	0.00257	CcSEcCtD
Orphenadrine—Urticaria—Prednisone—systemic scleroderma	0.000232	0.00252	CcSEcCtD
Orphenadrine—Somnolence—Methotrexate—systemic scleroderma	0.000217	0.00236	CcSEcCtD
Orphenadrine—Hypersensitivity—Prednisone—systemic scleroderma	0.000215	0.00234	CcSEcCtD
Orphenadrine—Asthenia—Prednisone—systemic scleroderma	0.00021	0.00228	CcSEcCtD
Orphenadrine—Pruritus—Prednisone—systemic scleroderma	0.000207	0.00224	CcSEcCtD
Orphenadrine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000201	0.00218	CcSEcCtD
Orphenadrine—Urticaria—Methotrexate—systemic scleroderma	0.000194	0.00211	CcSEcCtD
Orphenadrine—Dizziness—Prednisone—systemic scleroderma	0.000193	0.0021	CcSEcCtD
Orphenadrine—Vomiting—Prednisone—systemic scleroderma	0.000186	0.00202	CcSEcCtD
Orphenadrine—Headache—Prednisone—systemic scleroderma	0.000183	0.00199	CcSEcCtD
Orphenadrine—Hypersensitivity—Methotrexate—systemic scleroderma	0.00018	0.00195	CcSEcCtD
Orphenadrine—Asthenia—Methotrexate—systemic scleroderma	0.000175	0.0019	CcSEcCtD
Orphenadrine—Nausea—Prednisone—systemic scleroderma	0.000174	0.00188	CcSEcCtD
Orphenadrine—Pruritus—Methotrexate—systemic scleroderma	0.000173	0.00187	CcSEcCtD
Orphenadrine—Dizziness—Methotrexate—systemic scleroderma	0.000162	0.00175	CcSEcCtD
Orphenadrine—Vomiting—Methotrexate—systemic scleroderma	0.000155	0.00168	CcSEcCtD
Orphenadrine—Headache—Methotrexate—systemic scleroderma	0.000153	0.00166	CcSEcCtD
Orphenadrine—Nausea—Methotrexate—systemic scleroderma	0.000145	0.00157	CcSEcCtD
